Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
iCAD Inc (ICAD)
NASDAQ:ICAD
Holding ICAD?
Track your performance easily
ICAD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.18 - $2.65
Previous Close$1.54
Volume171.23K
Average Volume (3M)176.30K
Market Cap
$40.87M
Enterprise Value$22.49M
Total Cash (Recent Filing)$18.79M
Total Debt (Recent Filing)$415.00K
Price to Earnings (P/E)―
Beta1.78
Next Earnings
Feb 26, 2025EPS Estimate
-$0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding26,540,030
10 Day Avg. Volume420,996
30 Day Avg. Volume176,298
Standard Deviation0.23
R-Squared0.11
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)1.39
Price to Sales (P/S)2.62
Price to Cash Flow (P/CF)-6.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.42
Enterprise Value/Gross Profit1.52
Enterprise Value/Ebitda-4.73
Forecast
1Y Price Target
$3.00Price Target Upside94.81% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
iCAD News
PremiumCompany Announcements
iCAD, Inc. Reports Growth in ARR and RevenuePremiumPre-Earnings
iCAD Inc (ICAD) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
iCAD Inc (ICAD) Q2 Earnings Cheat Sheet
Ownership Overview
5.63%
Insiders
11.53% Mutual Funds
8.02% Other Institutional Investors
70.50% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ICAD FAQ
What was iCAD Inc’s price range in the past 12 months?
iCAD Inc lowest stock price was $1.18 and its highest was $2.65 in the past 12 months.
What is iCAD Inc’s market cap?
Currently, no data Available
When is iCAD Inc’s upcoming earnings report date?
iCAD Inc’s upcoming earnings report date is Feb 26, 2025 which is in 95 days.
How were iCAD Inc’s earnings last quarter?
iCAD Inc released its earnings results on Nov 13, 2024. The company reported -$0.07 earnings per share for the quarter, beating the consensus estimate of -$0.083 by $0.013.
Is iCAD Inc overvalued?
According to Wall Street analysts iCAD Inc’s price is currently Undervalued.
Does iCAD Inc pay dividends?
iCAD Inc does not currently pay dividends.
What is iCAD Inc’s EPS estimate?
iCAD Inc’s EPS estimate is -$0.06.
How many shares outstanding does iCAD Inc have?
iCAD Inc has 26,540,030 shares outstanding.
What happened to iCAD Inc’s price movement after its last earnings report?
iCAD Inc reported an EPS of -$0.07 in its last earnings report, beating expectations of -$0.083. Following the earnings report the stock price went down -23.932%.
Which hedge fund is a major shareholder of iCAD Inc?
Among the largest hedge funds holding iCAD Inc’s share is First Eagle Investment Management LLC. It holds iCAD Inc’s shares valued at 1M.
---
iCAD Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$3.00 (94.81% Upside)
$3.00 (94.81% Upside)
Blogger Sentiment
Bullish
ICAD Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 26.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 3.5%
Last 30 Days ▼ 3.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.46%
12-Months-Change
Fundamentals
Return on Equity
-17.56%
Trailing 12-Months
Asset Growth
-19.03%
Trailing 12-Months
Company Description
iCAD Inc
iCAD, Inc. engages in the provision of advanced image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer. It operates through the Cancer Detection and Cancer Therapy business segments. The Cancer Detection segment includes image analysis and clinical decision support solutions for mammography, breast tomosynthesis, and computed tomography imaging. The Cancer Therapy segment offers an isotope-free cancer treatment platform technology. The company was founded in 1984 and is headquartered in Nashua, NH.
---
ICAD Earnings Call
Q3 2024
0:00 / 0:00
---
ICAD Stock 12 Month Forecast
Average Price Target
$3.00
▲(94.81% Upside)
Technical Analysis
Best Analysts Covering ICAD
1 Year
1 Year Success Rate
6/22 ratings generated profit
1 Year Average Return
-34.88%
reiterated a buy rating 11 days ago
Copying Marie Thibault's trades and holding each position for 1 Year would result in 27.27% of your transactions generating a profit, with an average return of -34.88% per trade.
---